Optimizing Lentiviral Vector Production: Insights Into PiggyBac Transposase and Concatemeric Array Strategies
Biotechnology Journal · 2025
DOI: 10.1002/biot.70135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Jona Röscheise und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Biotechnology, Biberach University of Applied Sciences, Biberach, Germany. Hauptthemen laut MEDLINE: Transposases, Genetic Vectors, Lentivirus. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lentiviral vectors (LVVs) are essential tools in gene and cell therapy due to their ability to transduce both dividing and non‐dividing cells. Conventional production by transient plasmid co‐transfection is variable, costly, and difficult to scale, prompting development of stable producer cell lines. Historically, the GPRTG cell line has been generated using concatemeric‐array integration, which requires high DNA input, complex workflows, and can cause genetic instability. To address these limitations, we evaluated a transposase‐mediated integration strategy. Compared with the concatemeric‐array method, transposase‐based integration enabled faster recovery after selection with only a mild viability crisis and required substantially less DNA. This approach generated highly diverse and heterogeneous producer pools, providing a strong basis for subsequent clonal selection. During LVV production, both methods maintained comparable cell growth stability. However, concatemeric‐derived pools exhibited greater variability in recovery kinetics, viable cell density, and LVV titers, despite achieving the highest maximum titers overall. In contrast, transposase‐mediated pools showed more consistent performance, supporting their reliability for large‐scale applications. In summary, transposase‐based integration offers a robust and scalable alternative to concatemeric‐array methods for generating stable LVV producer cell lines, with significant potential to streamline LVV manufacturing for gene therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Applied Biotechnology, Biberach University of Applied Sciences, Biberach, Germany.
- Department of Gene Therapy, University Ulm, Ulm, Germany.
- Biopharmaceutical Product Development, CSL Behring Innovation GmbH, Marburg, Germany.
ORCID-Profile: Jona Röscheise, Maximilian Klimpel
Zitieren
APA
Röscheise, J., Klimpel, M., Hoffman, J., Pabbathi, V., Dersch, H., Govindarajan, P., Laux, H., & Otte, K. (2025). Optimizing Lentiviral Vector Production: Insights Into PiggyBac Transposase and Concatemeric Array Strategies. Biotechnology Journal. https://doi.org/10.1002/biot.70135
Vancouver
Röscheise J, Klimpel M, Hoffman J, Pabbathi V, Dersch H, Govindarajan P, et al. Optimizing Lentiviral Vector Production: Insights Into PiggyBac Transposase and Concatemeric Array Strategies. Biotechnology Journal. 2025. doi:10.1002/biot.70135
BibTeX
@article{Rscheise2025,
author = {Röscheise, Jona and Klimpel, Maximilian and Hoffman, Janina and Pabbathi, Vathsalya and Dersch, Herbert and Govindarajan, Parameswari and Laux, Holger and Otte, Kerstin},
title = {Optimizing Lentiviral Vector Production: Insights Into PiggyBac Transposase and Concatemeric Array Strategies},
journal = {Biotechnology Journal},
year = {2025},
doi = {10.1002/biot.70135}
}
EUVIMED